Melanoma Research Alliance Logo

MRA Home  |  Contact Us  

     
Follow MRA on Facebook MRA on Twitter
  • About Melanoma
    What is Melanoma Overview Educate Yourself
  • About MRA
    Overview Board of Directors Leadership Scientific Advisory Board Grant Review Committee
  • Research
    Research Overview Request for Proposals 2008 Research Awards 2009 Research Awards
  • News
  • Resources
    Publications PSA Downloads Scientific Retreat Presentations
  • Join MRA
  • MRA Research Awards Overview
  • Request for Proposals
  • 2008 Research Awards
  • 2009 Research Awards
Award Type
Team Science Award
Established Investigator Award
Young Investigator Award
Pilot Award
Development Award
Year
2008
2009
2009 Results


Young Investigator Awards

  • 18F Labeled benzamides for pre-clinical PET imaging of melanoma
  • Combining an MDM2 inhibitor with chemotherapy for the treatment of melanoma
  • The role of oncogenic signaling pathways in human melanoma immune evasion

Established Investigator Awards

  • Targeting signaling pathways for therapy in a new mouse model of melanoma
  • Development of intra-tumoral prognostic biomarkers for primary melanoma
  • Treatment of melanoma combining cancer gene therapy and immunotherapy
  • A phase I trial of bevacizumab plus ipilimumab in melanoma patients
  • Targeting the IGF1R pathway in melanoma
  • Targeted strategy for treatment of melanoma

Pilot Awards

  • Sulforaphane, a melanoma prevention agent for high-risk MC1R genotypes
  • Mechanisms of melanoma treatment resistance
  • Treatment of established melanoma by tumor-specific Th17 cells


Development Award

  • Transcriptome sequencing to detect gene fusions in melanoma

Science Awards

  • Developing Melanoma Screening in Primary Care
  • Manipulating Immune Regulation in Adoptive T-cell Therapy for Melanoma
  • Identification and Validation of Combination Therapies for Melanomas
  • Sequencing of the Melanoma Exome, Transcriptome and Epigenome
  • ombinatorial Immunotherapy for Melanoma with B7-H1/PD-1 Checkpoint Blockade
  • Identification of Novel Melanoma Risk Genes Using High-throughput Genomics
  • Defining the Importance of Immunity to NY-ESO-1 in Melanoma



Melanoma Research Alliance  |  1101 New York Avenue, NW, Suite 620, Washington, DC 20005  |  info@melanomaresearchalliance.org